Erratum: The association between two polymorphisms in the TS gene and risk of cancer: A systematic review and pooled analysis (International Journal of Cancer (2012) 131:9 (2103-16) DOI: 10.1002/ijc.27465);The association between two polymorphisms in the TS gene and risk of cancer: A systematic review and pooled analysis

International Journal of Cancer

Volumn 131, Issue 9, 2012, Pages 2103-2116

  Zhou, Jue Yu ^a   Shi, Rong ^a   Yu, Hai Lang ^a   Zeng, Ye ^a   Zheng, Wen Ling ^a   Ma, Wen Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

cancer risk; meta analysis; polymorphism; thymidylate synthase

Indexed keywords

ARGININE; THYMIDYLATE SYNTHASE;

ASIAN; BREAST CANCER; CANCER RISK; CAUCASIAN; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DOMINANT GENE; ENHANCER REGION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW (TOPIC); TS GENE; TUMOR GENE;

EID: 84865544290     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27998     Document Type: Erratum

References (49)

1. Shrubsole MJ, Jin F, Dai Q, Shu XO, Potter JD, Hebert JR, Gao YT, Zheng W,. Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res 2001; 61: 7136-41. (Pubitemid 32946506)
2. Kim YI,. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1999; 10: 66-88.
3. Duthie SJ,. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999; 55: 578-92.
4. Ames BN,. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001; 475: 7-20. (Pubitemid 32284938)
5. Sharp L, Little J,. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004; 159: 423-43. (Pubitemid 38280289)
6. Lucock M,. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71: 121-38.
7. Kamb A, Finer-Moore J, Calvert AH, Stroud RM,. Structural basis for recognition of polyglutamyl folates by thymidylate synthase. Biochemistry 1992; 31: 9883-90.
8. Moertel CG,. Chemotherapy for colorectal cancer. N Engl J Med 1994; 330: 1136-42. (Pubitemid 24118273)
9. Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S, Matsuda H,. New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction. Int J Cancer 2003; 104: 790-5. (Pubitemid 36418519)
10. Chu E, Koeller DM, Casey JL, Drake JC, Chabner BA, Elwood PC, Zinn S, Allegra CJ,. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci USA 1991; 88: 8977-81. (Pubitemid 21915553)
11. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD,. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 2000; 9: 1381-5. (Pubitemid 32044809)
12. Henriquez-Hernandez LA, Murias-Rosales A, Hernandez Gonzalez A, Cabrera De Leon A, Diaz-Chico BN, Mori De Santiago M, Fernandez Perez L,. Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep 2009; 22: 1425-33.
13. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Toloczko-Grabarek A, Gilbert M, Edler L, Zapatka M, Eils R, Lubinski J, et al. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat 2010; 119: 201-11.
14. Kumar K, Vamsy M, Jamil K,. Thymidylate synthase gene polymorphisms effecting 5-FU response in breast cancer patients. Cancer Biomark 2010; 6: 83-93.
15. Naushad SM, Reddy CA, Rupasree Y, Pavani A, Digumarti RR, Gottumukkala SR, Kuppusamy P, Kutala VK,. Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancer. Cell Biochem Biophys 2011; 61: 715-23.
16. Nordgard SH, Alnaes GI, Hihn B, Lingjaerde OC, Liestol K, Tsalenko A, Sorlie T, Lonning PE, Borresen-Dale AL, Kristensen VN,. Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival. Int J Cancer 2008; 123: 577-85. (Pubitemid 351898415)
17. Kim HN, Kim YK, Lee IK, Lee JJ, Yang DH, Park KS, Choi JS, Park MR, Jo DY, Kim HJ,. Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. Am J Hematol 2007; 82: 798-801.
18. Kasperzyk JL, Chang ET, Birmann BM, Kraft P, Zheng T, Mueller NE,. Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study. Am J Epidemiol 2011; 174: 816-27.
19. Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q,. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 2007; 109: 3050-9. (Pubitemid 46482106)
20. Gast A, Bermejo JL, Flohr T, Stanulla M, Burwinkel B, Schrappe M, Bartram CR, Hemminki K, Kumar R,. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 2007; 21: 320-5. (Pubitemid 46158126)
21. Canalle R, Silveira VS, Scrideli CA, Queiroz RG, Lopes LF, Tone LG,. Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2011; 52: 1118-26.
22. Chan JY, Ugrasena DG, Lum DW, Lu Y, Yeoh AE,. Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 2011; 29: 116-23.
23. Gao CM, Takezaki T, Wu JZ, Liu YT, Ding JH, Li SP, Su P, Hu X, Kai HT, Li ZY, Matsuo K, Hamajima N, et al. Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac J Cancer Prev 2004; 5: 133-8.
24. Tan W, Miao X, Wang L, Yu C, Xiong P, Liang G, Sun T, Zhou Y, Zhang X, Li H, Lin D,. Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. Carcinogenesis 2005; 26: 1430-5. (Pubitemid 41417886)
25. Wang LD, Guo RF, Fan ZM, He X, Gao SS, Guo HQ, Matsuo K, Yin LM, Li JL,. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 2005; 18: 177-84. (Pubitemid 41801113)
26. Zhang Z, Xu Y, Zhou J, Wang X, Wang L, Hu X, Guo J, Wei Q, Shen H,. Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis. Carcinogenesis 2005; 26: 1764-9. (Pubitemid 41487992)
27. Adleff V, Hitre E, Koves I, Orosz Z, Hajnal A, Kralovanszky J,. Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients. Int J Cancer 2004; 108: 852-6. (Pubitemid 38112613)
28. Carmona B, Guerreiro C, Cravo M, Nobre-Leitao C, Brito M,. 5' and 3' UTR thymidylate synthase polymorphisms modulate the risk of colorectal cancer independently of the intake of methyl group donors. Mol Med Report 2008; 1: 747-52.
29. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS,. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 2007; 28: 1672-9. (Pubitemid 47303944)
30. Goode EL, Potter JD, Bigler J, Ulrich CM,. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 157-62. (Pubitemid 38116635)
31. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD,. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res 2002; 62: 3361-4. (Pubitemid 34651378)
32. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML,. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2509-16. (Pubitemid 41752708)
33. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
34. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
35. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-60. (Pubitemid 37088507)
36. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34. (Pubitemid 27387172)
37. Kristensen MH, Pedersen PL, Melsen GV, Ellehauge J, Mejer J,. Variants in the dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidylate synthase genes predict early toxicity of 5-fluorouracil in colorectal cancer patients. J Int Med Res 2010; 38: 870-83.
38. Curtin K, Ulrich CM, Samowitz WS, Bigler J, Caan B, Potter JD, Slattery ML,. Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer 2007; 120: 2226-32. (Pubitemid 46555863)
39. Choi SW, Mason JB,. Folate and carcinogenesis: an integrated scheme. J Nutr 2000; 130: 129-32. (Pubitemid 30073783)
40. Chu E, Allegra CJ,. The role of thymidylate synthase in cellular regulation. Adv Enzyme Regul 1996; 36: 143-63. (Pubitemid 27065709)
41. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K,. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995; 20: 191-7.
42. Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, Iqbal S, Lenz HJ, Ladner RD,. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 2004; 14: 319-27. (Pubitemid 38638919)
43. Marsh S, Collie-Duguid ES, Li T, Liu X, McLeod HL,. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics 1999; 58: 310-2. (Pubitemid 29300314)
44. Zhuang W, Wu XT, Zhou Y, Liu GJ, Wu TX, Yao X, Du L, Wei ML,. Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions and gastric cancer. Dig Dis Sci 2009; 54: 1379-85.
45. Chen J, Hunter DJ, Stampfer MJ, Kyte C, Chan W, Wetmur JG, Mosig R, Selhub J, Ma J,. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 958-62. (Pubitemid 37310249)
46. Wang J, Wang B, Bi J, Di J,. The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2011; 128: 203-9.
47. Weng Y, Zhang J, Tang X, Xie X, Chen G,. Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis. Leuk Lymphoma 2012.
48. Kawakami K, Watanabe G,. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res 2003; 63: 6004-7. (Pubitemid 37187503)
49. Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ, Ladner RD,. A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 2003; 63: 2898-904. (Pubitemid 36667162)